NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
复制标题
DOI:
10.3892/or.2017.5649
复制
发表时间:
2017-07
期刊:
影响因子:
4.2
通讯作者:
Yan Wang;Zhiqiang Peng;R. Meng;T. Tao;Qiqi Wang;Chunjuan Zhao;Hua Liu;Ran Song;Junfang Zheng-Ju
中科院分区:
文献类型:
--
作者:
Yan Wang;Zhiqiang Peng;R. Meng;T. Tao;Qiqi Wang;Chunjuan Zhao;Hua Liu;Ran Song;Junfang Zheng-Ju
G protein-coupled estrogen receptor (GPER) signaling is activated in triple-negative breast cancer (TNBC); however, the detailed mechanisms of its regulation remain unclear. The present study aimed to elucidate the molecular mechanisms involved in GPER activation in TNBC. In MDA-MB-231 cells, a TNBC cell line, NHERF1 interaction with GPER was verified by co-immunoprecipitation and immunofluorescent staining assays. Overexpression of NHERF1 in MDA-MB-231 cells inhibited GPER-mediated proliferation and phosphorylation of ERK1/2 and Akt. Furthermore, NHERF1 expression levels were negatively correlated with the gene signatures of GPER activation, ERK1/2 and Akt signaling, and cell proliferation in early stage of TNBC tumors from the TCGA data set. Taken together, NHERF1 inhibited the activation of GPER-mediated signaling and suppressed the proliferation of triple-negative breast cancer cells. Loss of NHERF1 expression may play a pivotal role in the early stage of TNBC carcinogenesis.